Landos Biopharma, Inc. LABP
Set alert
22.93 +22.93 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 71.68M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -11.08
- Beta
- 0.00
- Short ratio
- 0.08
- Inst. own
- 52.04%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 9, 2024
- 50-d avg
- 20.19
- 200-d avg
- 8.35
- 1y target
- 12.71
Period ending Mar 31, 2024 · select a line to chart its history
Income statement
| 9.29M | |
| 3.15M | |
| 6.14M | |
| -9.29M | |
| -8.90M | |
| -8.90M | |
| -8.90M | |
| -8.90M | |
| -1.43 | |
| -1.43 | |
| -1.43 | |
| -8.90M | |
| -8.90M | |
| 6.21M | |
| 6.21M |
Balance sheet
| 29.05M | |
| 29.05M | |
| 29.90M | |
| 29.90M | |
| 6.74M | |
| 6.74M | |
| -164.26M | |
| 23.15M | |
| 23.15M | |
| 1.56M |
Cash flow
| -8.50M | |
| -8.50M | |
| 3.00K | |
| 260.00K |